Joey Moore
Member
Market Overview
The Latin America hypodermic syringes and needles market size reached USD 207.12 Million in 2024. Forecasts by IMARC Group project the market to expand to USD 365.07 Million by 2033, growing at a CAGR of 5.85% during 2025-2033. Expansion is driven by increased vaccination programs, a rise in chronic diseases, advancements in needle technology, government initiatives on safe injection practices, and heightened awareness of needlestick injury prevention.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
- Current Market Size: USD 207.12 Million in 2024
- CAGR: 5.85%
- Forecast Period: 2025-2033
- Extensive government-led immunization and vaccination programs are fueling market growth, with influenza vaccine purchase in Argentina projected to rise from 1.2 million to over 4 million doses by 2025.
- Increased government healthcare spending enhances public health funding, supporting wider access to syringes and needles, exemplified by Brazil's USD 40 million allocation for aeromedical goods.
- Sustainability is a growing focus, with the Environmental Alliance of America promoting eco-labeling and development of biodegradable and recyclable syringes in 2024.
- The market includes partnerships with global manufacturers to ensure continuous distribution of essential medical products, emphasizing preventive healthcare.
- Regulatory bodies encourage greener technologies, fostering research and innovation toward eco-conscious healthcare solutions.
- The market spans several countries including Brazil, Mexico, Argentina, Colombia, Chile, and Peru.
Market Growth Factors
Increased Focus on Immunization and Vaccination Programs
The growth of the Latin America hypodermic syringe and needle market is driven by the initiatives taken by the governments to increase vaccination and immunization programs. The government of Argentina is expected to increase its purchase of influenza vaccines from domestic suppliers from 1.2M doses to over 4M doses by 2025. From an operational perspective, Argentina's National Ministry of Health, in conjunction with the Pan American Health Organization (PAHO), promotes access to safe, effective, quality and affordable medicines and health technologies. This includes vaccinations against infectious diseases like influenza and COVID-19, creating consistent demand for good quality needles and syringes throughout the country. The increase in focus on healthcare prevention helps improve the market further, as well as tapping into international medical supply companies to allow product availability.
Increased Government Spending on Healthcare
Government investment in healthcare and rising healthcare public spending are predicted to encourage the growth of the hypodermic syringe and needle market outlook in Latin America due to increased access to syringes and needles in vaccination programs and regular procedures in many countries. Regional governments are upgrading their aerobic systems to meet their patient demands and this opens additional opportunities. The ITA report notes that the 2024 Brazil Aeromedical Trade Mission is expected to help US suppliers meet and develop new and existing connections to Brazil's expanding aeromedical market. Additionally, in light of the requested USD 40 million, the Brazilian government asked for access to Brazilian public procurement, and for the forging of relationships with Brazilian medical device manufacturers, to guarantee a reliable supply of good quality products.
Increased Focus on Sustainability and Eco-Friendly Solutions
Sustainability trends emerge more and more in the Latin America hypodermic syringes and needles market. Growing environmental concerns are driving healthcare professionals and manufacturers toward adoption of eco-friendly materials and production practices. The Environmental Alliance of America established itself in 2024 helped by the UN Environment Program (UNEP), and Germany funded it. It created the region's first eco-labeling program to ease sustainable trade and help over 450 million people make better informed consumer choices through information on product environmental impacts. Market players are addressing this issue with the development of biodegradable and recyclable syringes and needles, which save medical waste and reduce the adverse ecological impact. Governments and medical organizations are promoting green manufacturing modes along with encouraging investments in R&D for innovation and a green sustainable healthcare ecosystem for the industry.
Market Segmentation
Product Insights
- Hypodermic Syringes
- Conventional Syringes: Traditional syringes used for various medical applications.
- Safety Syringes:
- Retractable Safety Syringes: Syringes designed with mechanisms to retract needles post-use, enhancing safety.
- Non-retractable Safety Syringes: Safety syringes without retractable mechanisms, designed to prevent needlestick injuries.
- Hypodermic Needles
- Conventional Needles: Standard needles used for injections and other medical procedures.
- Safety Needles: Needles equipped with safety features to minimize injury and contamination risks.
- Hospitals: Primary use of syringes and needles for inpatient care and procedures.
- Clinics: Usage in outpatient facilities for injections and diagnostic purposes.
- Ambulatory Surgical Centers: Facilities offering surgical surgical procedures utilizing syringes and needles.
- Veterinary: Application in animal healthcare for medication administration and procedures.
- Home Care: Usage in home-based healthcare settings for treatments and injections.
- Others: Additional diverse end-use categories not specified.
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Others
Brazil is identified as a key regional market within Latin America for hypodermic syringes and needles. The region benefits from increasing government healthcare investment and a growing aeromedical sector, supported by collaborations such as the 2024 Brazil aerobic trade mission and government allocations like the USD 40 million designated for aeromedical goods and services. These initiatives promote steady market growth and partnerships with global suppliers, underpinning Brazil's dominant position in the regional market.
Recent Developments & News
In September 2024, the US FDA approved B. Braun Medical's Introcan Safety 2 Deep Access IV Catheter, which extends the catheter's dwell length from the typical 3.8 days to about 5.7 days. This device reduces blood exposure and offers automatic passive needlestick protection, designed for patients with difficult vascular access. On August 28, 2024, the Brazilian Secretariat of International Trade (SECEX) initiated an antidumping investigation into imports of hypodermic needles from China, following a complaint by Becton Dickinson Indústrias Cirúrgicas Ltda. The investigation involves products under NCM code 9018.32.19 with an intentional dumping margin of 16.93 USD/kg (261.7%), and stakeholders were invited to participate by September 17, 2024.
Key Players
- B. Braun Medical
- Becton Dickinson Industrias Cirúrgicas Ltda.
About Us
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, considerations studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.